drugset / Trial / NCT02385656

The Efficacy and Tolerability of Modafinil for Fatigue and Daytime Sleepiness in Cancer Patients: Preliminary Study

NCT02385656

Phase 4 Unknown 20 enrolled Seoul National University Bundang Hospital
NaSingle-groupOpen-labelTreatment

Summary

Open-pilot study for the efficacy and tolerability of modafinil on the fatigue and somnolence in cancer-patients.

Timeline

Start
2013-03
Primary completion
2016-02
Completion
2016-02

Drugs

EvaluationDrugModalityDoseRoute
Subject Modafinil Small molecule 200 mg

Indications

No indication recorded.